Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to assess the effect of PYM50028 administered once daily for up to 12 weeks on the memory and other faculties of subjects with dementia due to Alzheimer\'s disease.
Epistemonikos ID: 615974aff4643e9b220f37805af64dc21c858e71
First added on: May 04, 2024